Nicotine Replacement Therapy Distribution to Light Daily Smokers Calling a Quitline

被引:11
|
作者
Krupski, Laurie [1 ]
Cummings, K. Michael [1 ,2 ]
Hyland, Andrew [1 ]
Carlin-Menter, Shannon [1 ,3 ]
Toll, Benjamin A. [4 ]
Mahoney, Martin C. [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Hlth Behav, Buffalo, NY 14263 USA
[2] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[3] SUNY Buffalo, Dept Family Med, Buffalo, NY 14260 USA
[4] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA
关键词
NATURAL-HISTORY; SMOKING; EFFICACY; WITHDRAWAL; CESSATION; LOZENGE; PROGRAM; REACH;
D O I
10.1093/ntr/ntt021
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: With an increasing prevalence of lighter smokers presenting for cessation assistance, outcome-based recommendations are needed to inform nicotine replacement therapy (NRT) distribution protocols by quitlines. Methods: A quasi-experimental design was utilized to compare quit rates based on samples selected from the time period before and after NRT (gum or lozenge) was offered to light daily smokers (1-9 cigarettes) contacting the New York State Smokers' Quitline. Outcome measures included self-reported 7- and 30-day abstinence rates, numbers of daily cigarettes among continuing smokers, and cost per quit analyses. Results: Among responders to the follow-up survey, quit rates were higher for those given NRT compared with those not offered NRT at both 7 (33.0% vs. 27.2%; Relative Risk [RR] = 2.25 [95% CI: 1.15, 4.40;p < .05]) and 30 days (28.0% vs. 21.9%; RR = 2.63 [95% CI: 1.25, 5.54; p < .05]). Similar results were obtained based on intent-to-treat analyses for both 7 (13.4% vs. 11.3%; RR = 1.92 [95% CI: 1.08, 3.39;p < .05]) and 30 days (11.4% vs. 9.1%; RR = 2.29 [95% CI: 1.20, 4.40; p < .05]). Among continuing smokers, the mean number of cigarettes smoked per day increased from enrollment to follow-up in both groups, but less so in those receiving NRT. The additional cost associated with providing a 2-week free supply of nicotine replacement to smokers was $52 for gum and $74 for lozenge. Conclusions: This study demonstrates that light daily smokers (1-9 cigarettes) who contact a telephone quitline are interested in using NRT if offered and are able to achieve higher quit rates compared with those not offered NRT.
引用
收藏
页码:1572 / 1577
页数:6
相关论文
共 50 条
  • [21] The impact of nicotine replacement therapy on the mortality of critically III smokers
    Shah, S.
    McKenzie, C. A.
    Collins, J.
    Whitely, C.
    Gillies, M.
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 1030 - 1030
  • [22] Smokers' expectancies for nicotine replacement therapy vs. cigarettes
    Juliano, LM
    Brandon, TH
    [J]. NICOTINE & TOBACCO RESEARCH, 2004, 6 (03) : 569 - 574
  • [23] EFFECTS OF A NOVEL NICOTINE REPLACEMENT THERAPY SAMPLING INTERVENTION ON DAILY CIGARETTE USE IN LOW-INCOME SMOKERS
    Gajos, Jamie
    Sisson, Michelle
    Wolford-Clevenger, Caitlin
    Chichester, Keith
    Hill, Samantha
    Businelle, Michael S.
    Cropsey, Karen
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S259 - S259
  • [24] Does free nicotine replacement therapy for young adults prompt them to call a quitline?
    Maher, Julie E.
    Rohde, Kristen
    Pizacani, Barbara
    Dent, Clyde
    Stark, Michael J.
    Dilley, Julia A.
    Pickle, Kathryn E.
    Boysun, Michael J.
    Thompson, Juliet R.
    Yepassis-Zembrou, Patricia
    [J]. TOBACCO CONTROL, 2007, 16 (05) : 357 - 358
  • [25] Counseling alone or in combination with nicotine replacement therapy for treatment of black non-daily smokers: a randomized trial
    Nollen, Nicole L.
    Cox, Lisa Sanderson
    Mayo, Matthew S.
    Ellerbeck, Edward F.
    Ahluwalia, Jasjit S.
    [J]. ADDICTION, 2020, 115 (08) : 1547 - 1560
  • [26] Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public
    Etter, JF
    Perneger, TV
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 175 - 183
  • [27] Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy
    Lawson, GM
    Hurt, RD
    Dale, LC
    Offord, KP
    Croghan, IT
    Schroeder, DR
    Jiang, NS
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (06): : 510 - 516
  • [28] Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy
    Lawson, GM
    Hurt, RD
    Dale, LC
    Offord, KP
    Croghan, IT
    Schroeder, DR
    Jiang, NS
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (06): : 502 - 509
  • [29] Nicotine and cotinine plasma concentrations: Useful markers to optimize nicotine replacement therapy in smokers
    Baraldo, M.
    Franceschi, L.
    Rosa, I
    Furlanut, M.
    [J]. THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 484 - 484
  • [30] Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy
    Biazzo, Laura L.
    Froshaug, Desiree B.
    Harwell, Todd S.
    Beck, Heather N.
    Haugland, Cynthia
    Campbell, Stacy L.
    Helgerson, Steven D.
    [J]. NICOTINE & TOBACCO RESEARCH, 2010, 12 (06) : 567 - 573